Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Evaluating the economic implications of cardiovascular therapeutics.
Califf
R M
RM
Duke Clinical Research Institute, Durham, NC 27715, USA.
D002317:Cardiovascular Agents / Q000191:economics* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D003362:Cost-Benefit Analysis; D019049:Developed Countries; D016527:Drug Costs; D017850:Economics, Pharmaceutical; D006801:Humans
D002317:Cardiovascular Agents